Global Blood Therapeutics (GBT) ROE US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -36.7% | -30.4% | -46.1% | -59.5% | -154.3% | -275.7% | ||
| Changes by years, y/y, % | +8pp | +6pp | -16pp | -13pp | -95pp | +28.4% | |||
Global Blood Therapeutics. ROE, %
Global Blood Therapeutics. ROE, changes, pp
Global Blood Therapeutics (GBT) ROE US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| ROE, % | ? | -84.3% | -90.0% | -156.3% | -234.0% | -275.7% | -275.7% | |
| Changes by years, y/y, % | -27pp | -28pp | -97pp | -165pp | -191pp | |||
| Changes by quarters, q/q, % | -16pp | -6pp | -66pp | -78pp | -42pp | |||